Results 161 to 170 of about 149,546 (225)

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists. [PDF]

Curr Opin Rheumatol
Ford JA, Gewurz-Singer O.
europepmc   +1 more source

When "Low-Grade" Is No Longer Low Risk in IgA Nephropathy. [PDF]

Clin J Am Soc Nephrol
Vaughan E, Perkovic V.
europepmc   +1 more source

Real-world study of telitacicept in the treatment of IgA nephropathy. [PDF]

Front Immunol
Hu L, Meng M, Jiao Y, Yang J, Fan Y, Liu X, Liu B, Wang L.   +7 more
europepmc   +1 more source

External validation of the international IgA nephropathy prediction tool in a Thai cohort. [PDF]

Front Med (Lausanne)
Phongphithakchai A, Thongrueang A, Srithongkul T, Raksasuk S, Kawakami F, Tedasen A, Chatatikun M.   +6 more
europepmc   +1 more source

Role of Omega-3 Fatty Acids in IgA Nephropathy: An Updated Review of Mechanisms and Evidence. [PDF]

J Clin Med
Taskapan H, Kugathasan L, Faruque L, Sikaneta T, Tam P.   +4 more
europepmc   +1 more source

Efficacy and safety of finerenone in adults with IgA nephropathy: a 12-month real-world study. [PDF]

Ren Fail
Pei J, Sun X, Xu X, Bai P, Huang R, Zhang J, Chen X, Yao L, Shao L, Li Y.   +9 more
europepmc   +1 more source

Finerenone in IgA nephropathy: a systematic review and meta-analysis. [PDF]

BMC Nephrol
Wu J, Li Y, Luo L, Wu Q, Mou Y, Xu Y, Li Q, Ren Q, Qiao Y, Huang W.   +9 more
europepmc   +1 more source

IgA nephropathy-associated breast milk B cell alterations. [PDF]

Front Immunol
Zachova K, Cutkova A, Kosztyu P, Ohyama Y, Takahashi K, Zadrazil J, Orsag J, Petejova N, Mestecky J, Raska M.   +9 more
europepmc   +1 more source

Endothelin Receptor Antagonists in Patients with IgA Nephropathy Treated with Sodium-Glucose Cotransporter 2 Inhibitors. [PDF]

J Am Soc Nephrol
Nachman PH.
europepmc   +1 more source

IgA nephropathy: Discovery of a distinct glomerular disorder

, 2008
Lai, KN, Glassock, RJ, Woo, KT
core